Rafferty Asset Management, LLC Horizon Therapeutics Public LTD CO Transaction History

Rafferty Asset Management, LLC

$26.7 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $663,858 - $776,268	-6,707 Reduced 8.01%	77,078 $8.92 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $2.11 Million - $2.46 Million	21,919 Added 35.43%	83,785 $8.62 Million
Q1 2023 May 11, 2023	SELL	$107.32 - $113.5 $2.26 Million - $2.39 Million	-21,019 Reduced 25.36%	61,866 $6.75 Million
Q4 2022 Feb 13, 2023	SELL	$62.39 - $113.8 $1.37 Million - $2.5 Million	-22,000 Reduced 20.98%	82,885 $9.43 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $3.54 Million - $5.09 Million	60,154 Added 134.48%	104,885 $6.49 Million

Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $661,640 - $969,627	-8,333 Reduced 15.7%	44,731 $3.57 Million
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $56,173 - $71,376	650 Added 1.24%	53,064 $5.58 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $2.32 Million - $2.82 Million	23,496 Added 81.25%	52,414 $5.65 Million
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $87,865 - $105,513	956 Added 3.42%	28,918 $3.17 Million
Q2 2021 Aug 10, 2021	BUY	$86.24 - $95.92 $2.05 Million - $2.28 Million	23,794 Added 570.87%	27,962 $2.62 Million
Q1 2021 May 10, 2021	SELL	$71.83 - $95.48 $160,252 - $213,015	-2,231 Reduced 34.86%	4,168 $384,000
Q4 2020 Feb 10, 2021	BUY	$67.0 - $84.39 $68,943 - $86,837	1,029 Added 19.16%	6,399 $468,000
Q3 2020 Nov 13, 2020	SELL	$55.23 - $79.93 $61,691 - $89,281	-1,117 Reduced 17.22%	5,370 $417,000
Q2 2020 Aug 07, 2020	BUY	$30.2 - $56.98 $195,907 - $369,629	6,487 New	6,487 $361,000
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $301,026 - $466,730	-12,104 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$25.43 - $36.67 $179,840 - $259,330	-7,072 Reduced 36.88%	12,104 $438,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $193,039 - $234,752	8,393 Added 77.84%	19,176 $522,000
Q2 2019 Aug 09, 2019	BUY	$22.81 - $28.48 $245,960 - $307,099	10,783 New	10,783 $259,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account